GeneDx Holdings Corp’s recently made public that its 10% Owner OPKO HEALTH, INC. unloaded Company’s shares for reported $3.18 million on Aug 08 ’24. In the deal valued at $31.82 per share,100,000 shares were sold. As a result of this transaction, OPKO HEALTH, INC. now holds 2,871,570 shares worth roughly $98.06 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, OPKO HEALTH, INC. sold 12,994 shares, generating $381,427 in total proceeds. Upon selling the shares at $29.35, the 10% Owner now owns 2,971,570 shares.
Before that, OPKO HEALTH, INC. sold 88,839 shares. GeneDx Holdings Corp shares valued at $2,976,346 were divested by the 10% Owner at a price of $33.50 per share. As a result of the transaction, OPKO HEALTH, INC. now holds 2,984,564 shares, worth roughly $101.92 million.
Craig Hallum initiated its GeneDx Holdings Corp [WGS] rating to a Buy in a research note published on July 10, 2024; the price target was $43.
Price Performance Review of WGS
On Tuesday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock jump 2.00% to $34.15. Over the last five days, the stock has gained 18.49%. GeneDx Holdings Corp shares have risen nearly 1141.82% since the year began. Nevertheless, the stocks have risen 548.01% over the past one year. While a 52-week high of $35.65 was reached on 08/13/24, a 52-week low of $1.16 was recorded on 01/02/24. SMA at 50 days reached $29.66, while 200 days put it at $13.12.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 32.84, which if violated will result in even more drops to 31.52. On the upside, there is a resistance level at 36.46. A further resistance level may holdings at 38.76. The Relative Strength Index (RSI) on the 14-day chart is 59.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.71, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 27.21%. Stochastics%K at 76.88% indicates the stock is a holding.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on
